donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
02327 MEILLEUREHEALTH
0.280
-0.010-3.45%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Cash flow from operating activities
Earning before tax
-17.26% 85.7M -- -- 2038.38% 103.59M -- --
Profit adjustment
Interest (income) - adjustment
-51.14% -12.45M -- -- 0.18% -8.24M -- --
Dividend (income)- adjustment
-- -- -- -- 23.28% -346K -- --
Attributable subsidiary (profit) loss
163.46% 11.07M -- -- -80.7% 4.2M -- --
Impairment and provisions:
821.51% 5.01M -- 0 -98.59% 544K -- 0
-Impairment of trade receivables (reversal)
431.21% 919K -- -- -96.82% 173K -- --
-Other impairments and provisions
1003.5% 4.09M -- -- -- 371K -- --
Revaluation surplus:
-1429.46% -32.27M -- 0 107.52% 2.43M -- 0
-Fair value of investment properties (increase)
-190.05% -15.19M -- -- 176.71% 16.87M -- --
-Derivative financial instruments fair value (increase)
-167.9% -184K -- -- -- 271K -- --
-Other fair value changes
-14.81% -16.89M -- -- -42.87% -14.71M -- --
Asset sale loss (gain):
-- 0 -- 0 -1019.14% -14.07M -- 0
-Loss (gain) from sale of subsidiary company
-- -- -- -- -- -14.07M -- --
Depreciation and amortization:
-54.79% 3.58M -- 0 27.73% 7.91M -- 0
-Depreciation
-53.67% 3.55M -- -- 29.16% 7.65M -- --
-Amortization of intangible assets
-88.28% 30K -- -- -4.12% 256K -- --
Financial expense
-38.72% 8.39M -- -- -16.54% 13.68M -- --
Exchange Loss (gain)
288.3% 3.75M -- -- -- -1.99M -- --
Special items
51.61% -13.43M -- -- -- -27.75M -- --
Operating profit before the change of operating capital
-25.77% 59.36M -- 0 112.28% 79.96M -- 0
Change of operating capital
Inventory (increase) decrease
169.04% 5.13M -- -- -277.89% -7.43M -- --
Developing property (increase)decrease
-161.83% -23.54M -- -- -1.16% -8.99M -- --
Accounts receivable (increase)decrease
-940.94% -93.65M -- -- -- 11.14M -- --
Accounts payable increase (decrease)
-277.02% -11.73M -- -- -6.19% 6.63M -- --
Cash  from business operations
-179.25% -64.43M -- 0 117.41% 81.31M -- 0
Other taxs
-79.37% -18.84M -- -- 23.44% -10.5M -- --
Net cash from operations
-217.6% -83.27M -119.02% -64.25M 178.66% 70.81M -165.88% -29.34M
Cash flow from investment activities
Interest received - investment
30.76% 12.41M -96.44% 125K 136.41% 9.49M -- 3.51M
Dividend received - investment
-96.16% 1.09M -96.19% 1.08M -- 28.3M -- 28.25M
Decrease in deposits (increase)
-- -363K -- -- -- -- -- --
Purchase of fixed assets
-614.79% -2.61M -261.11% -650K -170.37% -365K -- -180K
Purchase of intangible assets
32.69% -35K -- -- -1200% -52K -- -7K
Sale of subsidiaries
-- -- -- -- -- 14M -- --
Cash on investment
69.62% -3.87M -- -- 40.25% -12.75M -- --
Other items in the investment business
122.91% 154.95M 4507.98% 118.33M 126.61% 69.51M -- 2.57M
Net cash from investment operations
49.41% 161.56M 248.25% 118.88M 130.03% 108.14M 107.29% 34.14M
Net cash before financing
-56.25% 78.29M 1037.71% 54.63M 153.47% 178.94M 101.13% 4.8M
Cash flow from financing activities
New borrowing
249.19% 36.21M -- -- -95.7% 10.37M -- 9.97M
Refund
86.9% -23.54M 80.57% -16.73M -21.14% -179.7M -- -86.09M
Interest paid - financing
37.08% -8.28M 35.42% -4.27M 17.33% -13.16M -- -6.61M
Issuance expenses and redemption of securities expenses
-- -40.68M -- -- -- -- -- --
Pledged bank deposit (increase) decrease
-- -- -- -- 212.61% 82.68M -- 79.49M
Other items of the financing business
78.64% -1.94M 71.53% -1.05M -42.7% -9.07M -- -3.68M
Net cash from financing operations
64.9% -38.22M -218.83% -22.05M -133.22% -108.88M -101.72% -6.92M
Effect of rate
-113.25% -950K 17.81% -1.31M 260.04% 7.17M -2382.81% -1.59M
Net Cash
-42.81% 40.07M 1642.17% 32.59M 1114.71% 70.07M 89.86% -2.11M
Begining period cash
49.44% 233.47M 49.44% 233.47M -3.05% 156.23M -3.05% 156.23M
Cash at the end
16.76% 272.59M 73.57% 264.75M 49.44% 233.47M 8.76% 152.53M
Cash balance analysis
Cash and cash equivalent balance
-- 0 -- 0 -- 0 -- 0
Currency Unit
HKDHKDHKDHKD
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Zhonghui Anda accounting firm co., Ltd.--Zhonghui Anda accounting firm co., Ltd.--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Meirui Health International Industry Group Co., Ltd. is an investment holding company, mainly engaged in the sale and sale of health care products, chemical materials and building materials. The company operates through five business units. The Department of Health products, Chemical Materials and Building Materials is engaged in the business of buying and selling health products, chemical materials and building materials. The Research and Development Department is engaged in the research and development of chemical and biological products. The Investment and Finance Business Department is engaged in investment holding and finance business. Consultant and Marketing Agency Business Department is engaged in providing property marketing agency and consulting services. Property Development Department is engaged in the development of residential property business.
CEO: Xuzhou;cengwentao Zhou
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...